- Home
- / Flexion Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Flexion Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
$85.6 M
FY, 2020
CreditSafe Score
?
Score changed on Jul 14, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | 355.0K | 22.5M | 73.0M | 85.6M | |||
| Cost of goods sold | 4.0K | 7.3M | 10.0M | 19.2M | |||
| Gross profit | 351.0K | 15.2M | 63.0M | 66.3M | |||
| Gross profit margin, % | 98.9% | 67.4% | 86.3% | 77.5% | |||
| General and administrative expense | 9.1M | 13.4M | 28.5M | 78.8M | 121.3M | 129.7M | 105.0M |
| Operating expense total | 27.0M | 46.1M | 69.8M | 130.0M | 174.4M | 199.3M | 159.3M |
| EBIT | (27.0M) | (46.1M) | (69.8M) | (129.7M) | (159.2M) | (136.3M) | (93.0M) |
| EBIT margin, % | -36529.9% | -706.8% | -186.8% | -108.7% | |||
| Investment income | 478.7K | 1.2M | 1.5M | 3.7M | 4.6M | 3.2M | 876.0K |
| Interest expense | 326.4K | 252.4K | 2.1M | 7.8M | 10.5M | ||
| Pre tax profit | (113.2M) | ||||||
| Income tax expense | 495.0K | ||||||
| Net Income | (27.3M) | (46.3M) | (71.9M) | (137.5M) | (169.7M) | (149.8M) | (113.7M) |